MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cgh.2023.02.022

Медицинская библиотека · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023

Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma.

Crinò Stefano Francesco, Napoleon Bertrand, Facciorusso Antonio, Lakhtakia Sundeep, Borbath Ivan, Caillol Fabrice, Do-Cong Pham Khanh, Rizzatti Gianenrico, Forti Edoardo, Palazzo Laurent, Belle Arthur, Vilmann Peter, van Laethem Jean-Luc, Mohamadnejad Mehdi, Godat Sebastien, Hindryckx Pieter, Benson Ariel, Tacelli Matteo, De Nucci Germana, Binda Cecilia, Kovacevic Bojan, Jacob Harold, Partelli Stefano, Falconi Massimo, Salvia Roberto, Landoni Luca, ERASING study collaborators, Larghi Alberto

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND & AIMS: Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is emerging as a safe and effective treatment for pancreatic neuroendocrine tumors. We aimed to compare EUS-RFA and surgical resection for the treatment of pancreatic insulinoma (PI).

METHODS

Patients with sporadic PI who underwent EUS-RFA at 23 centers or surgical resection at 8 high-volume pancreatic surgery institutions between 2014 and 2022 were retrospectively identified and outcomes compared using a propensity-matching analysis. Primary outcome was safety. Secondary outcomes were clinical efficacy, hospital stay, and recurrence rate after EUS-RFA.

RESULTS

Using propensity score matching, 89 patients were allocated in each group (1:1), and were evenly distributed in terms of age, sex, Charlson comorbidity index, American Society of Anesthesiologists score, body mass index, distance between lesion and main pancreatic duct, lesion site, size, and grade. Adverse event (AE) rate was 18.0% and 61.8% after EUS-RFA and surgery, respectively (P < .001). No severe AEs were observed in the EUS-RFA group compared with 15.7% after surgery (P < .0001). Clinical efficacy was 100% after surgery and 95.5% after EUS-RFA (P = .160). However, the mean duration of follow-up time was shorter in the EUS-RFA group (median, 23 months; interquartile range, 14-31 months vs 37 months; interquartile range, 17.5-67 months in the surgical group; P < .0001). Hospital stay was significantly longer in the surgical group (11.1 ± 9.7 vs 3.0 ± 2.5 days in the EUS-RFA group; P < .0001). Fifteen lesions (16.9%) recurred after EUS-RFA and underwent a successful repeat EUS-RFA (11 patients) or surgical resection (4 patients).

CONCLUSION

EUS-RFA is safer than surgery and highly effective for the treatment of PI. If confirmed in a randomized study, EUS-RFA treatment can become first-line therapy for sporadic PI.

Для цитирования: Crinò Stefano Francesco, Napoleon Bertrand, Facciorusso Antonio, Lakhtakia Sundeep, Borbath Ivan, Caillol Fabrice, Do-Cong Pham Khanh, Rizzatti Gianenrico, Forti Edoardo, Palazzo Laurent, Belle Arthur, Vilmann Peter, van Laethem Jean-Luc, Mohamadnejad Mehdi, Godat Sebastien, Hindryckx Pieter, Benson Ariel, Tacelli Matteo, De Nucci Germana, Binda Cecilia, Kovacevic Bojan, Jacob Harold, Partelli Stefano, Falconi Massimo, Salvia Roberto, Landoni Luca, ERASING study collaborators, Larghi Alberto. Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2023. DOI: 10.1016/j.cgh.2023.02.022.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.